Aimmune Therapeutics, Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aimmune Therapeutics, Inc. for January 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 1,875 | 36,806 | 69,375 | |
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 38.15 | 1,875 | 71,531 | 0 | 1.9 K to 0 (-100.00 %) |
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 1,875 | 36,806 | 1,875 | 0 to 1.9 K |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 9,933 | 113,733 | 190,000 | |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 26,784 | 306,677 | 199,933 | |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 40.00 | 9,933 | 397,320 | 0 | 9.9 K to 0 (-100.00 %) |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 9,933 | 113,733 | 9,933 | 0 to 9.9 K |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 40.00 | 26,784 | 1,071,360 | 0 | 26.8 K to 0 (-100.00 %) |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 26,784 | 306,677 | 26,784 | 0 to 26.8 K |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 70,241 | |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.33 | 1,648 | 61,520 | 0 | 1.6 K to 0 (-100.00 %) |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 1,648 | 0 to 1.6 K |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 6,591 | 19,918 | 113,835 | |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 37.08 | 1,601 | 59,367 | 129 | 1.7 K to 129 (-92.54 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 37.12 | 4,990 | 185,223 | 1,730 | 6.7 K to 1.7 K (-74.26 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 6,591 | 19,918 | 6,720 | 129 to 6.7 K (+5,109.30 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 75,000 | 226,650 | 93,400 | |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.75 | 600 | 22,652 | 0 | 600 to 0 (-100.00 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,400 | 905,716 | 600 | 25 K to 600 (-97.60 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.86 | 300 | 11,359 | 25,000 | 25.3 K to 25 K (-1.19 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.13 | 24,700 | 917,022 | 25,300 | 50 K to 25.3 K (-49.40 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.78 | 599 | 22,629 | 50,000 | 50.6 K to 50 K (-1.18 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,401 | 905,811 | 50,599 | 75 K to 50.6 K (-32.53 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 75,000 | 226,650 | 75,000 | 0 to 75 K |